Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials (Q2320854): Difference between revisions

From MaRDI portal
Set OpenAlex properties.
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: Q5714616 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4428801 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Adaptive Methods for Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Hierarchical Proportional Hazards Regression Models for Highly Stratified Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance / rank
 
Normal rank
Property / cites work
 
Property / cites work: Markov Chain Monte Carlo Convergence Diagnostics: A Comparative Review / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3827377 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal designs and limiting optimal designs for a trinomial response / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Curve‐Free Method for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Analysis of Proportional Hazards Models Built from Monotone Functions / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Nonparametric Inference on the Dose Level with Specified Response Rate / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Designs for HIV Studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Measures of Model Complexity and Fit / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Based on Efficacy-Toxicity Trade-Offs / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios / rank
 
Normal rank

Latest revision as of 07:53, 20 July 2024

scientific article
Language Label Description Also known as
English
Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials
scientific article

    Statements

    Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials (English)
    0 references
    0 references
    27 August 2019
    0 references
    Bayesian adaptive methods
    0 references
    continual reassessment method (CRM)
    0 references
    maximum tolerated dose (MTD)
    0 references
    phase III clinical trial
    0 references
    surrogate efficacy
    0 references
    toxicity
    0 references
    trivariate binary outcome
    0 references
    nonparametric link functions
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references